Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 56 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

Assessing the distribution of cancer stem cells in tumorspheres.
Fotinós J, Marks MP, Barberis L, Vellón L
Sci Rep, 14(1):11013, 14 May 2024
Cited by: 0 articles | PMID: 38745039 | PMCID: PMC11094167
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer.
Giorello MB, Marks MP, Osinalde TM, Padin MDR, Wernicke A, Calvo JC, Chasseing NA, Vellón L
Cancer Epidemiol, 90:102573, 30 Apr 2024
Cited by: 0 articles | PMID: 38692143
Add to export list
Assessing the distribution of cancer stem cells in tumorspheres
Fotinós J, Marks MP, Barberis L, Vellón L
Research Square, 13 Mar 2024
Cited by: 0 articles | PPR: PPR820243
Add to export list Preprint v1
Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer.
Marks MP, Giménez CA, Isaja L, Vera MB, Borzone FR, Pereyra-Bonnet F, Romorini L, Videla-Richardson GA, Chasseing NA, Calvo JC, Vellón L
J Cancer Res Clin Oncol, 150(2):106, 28 Feb 2024
Cited by: 2 articles | PMID: 38418798 | PMCID: PMC10902018
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models.
Rodriguez MJ, Perrone MC, Riggio M, Palafox M, Salinas V, Elia A, Salgueiro ND, Werbach AE, Marks MP, Kauffman MA, Vellón L, Serra V, Novaro V
Sci Rep, 13(1):2710, 15 Feb 2023
Cited by: 6 articles | PMID: 36792625 | PMCID: PMC9932145
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models.
Rodriguez MJ, Perrone MC, Riggio M, Palafox M, Salinas V, Elia A, Salgueiro N, Werbach A, Marks MP, Kauffman MA, Vellón L, Serra V, Novaro V
Research Square, 28 Nov 2022
Cited by: 0 articles | PPR: PPR577155
Add to export list Preprint v1
Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α₆β₁ drives endocrine resistance in breast cancer cells.
Espinoza I, Yang L, Steen TV, Vellon L, Cuyàs E, Verdura S, Lau L, Menendez JA, Lupu R
Aging (Albany NY), 14(3):1200-1213, 11 Feb 2022
Cited by: 3 articles | PMID: 35148282 | PMCID: PMC8876916
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Understanding the influence of substrate when growing tumorspheres.
Benítez L, Barberis L, Vellón L, Condat CA
BMC Cancer, 21(1):276, 15 Mar 2021
Cited by: 1 article | PMID: 33722191 | PMCID: PMC7962376
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
Menendez JA, Papadimitropoulou A, Vander Steen T, Cuyàs E, Oza-Gajera BP, Verdura S, Espinoza I, Vellon L, Mehmi I, Lupu R
Cancers (Basel), 13(5):1132, 06 Mar 2021
Cited by: 19 articles | PMID: 33800852 | PMCID: PMC7961649
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer.
Menendez JA, Peirce SK, Papadimitropoulou A, Cuyàs E, Steen TV, Verdura S, Vellon L, Chen WY, Lupu R
Aging (Albany NY), 12(24):24671-24692, 10 Dec 2020
Cited by: 4 articles | PMID: 33335078 | PMCID: PMC7803566
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer.
Menendez JA, Mehmi I, Papadimitropoulou A, Vander Steen T, Cuyàs E, Verdura S, Espinoza I, Vellon L, Atlas E, Lupu R
Int J Mol Sci, 21(20):E7661, 16 Oct 2020
Cited by: 17 articles | PMID: 33081219 | PMCID: PMC7588883
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer.
Papadimitropoulou A, Vellon L, Atlas E, Steen TV, Cuyàs E, Verdura S, Espinoza I, Menendez JA, Lupu R
Int J Mol Sci, 21(20):E7737, 19 Oct 2020
Cited by: 7 articles | PMID: 33086721 | PMCID: PMC7589856
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Understanding the Influence of Substrate When Growing Tumorspheres
Benítez L, Barberis L, Vellón L, Condat CA
Research Square, 17 Sep 2020
Cited by: 0 articles | PPR: PPR216951
Add to export list Preprint v1
An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors.
Verdura S, Cuyàs E, Lozano-Sánchez J, Bastidas-Velez C, Llorach-Parés L, Fernández-Arroyo S, Hernández-Aguilera A, Joven J, Nonell-Canals A, Bosch-Barrera J, Martin-Castillo B, Vellon L, Sanchez-Martinez M, Segura-Carretero A, Menendez JA
Carcinogenesis, 40(1):27-40, 01 Mar 2019
Cited by: 10 articles | PMID: 30428017
Add to export list
Noncoding RNAs and Base Modifications: Epigenomic Players Implicated in Neurological Disorders and Tumorigenesis.
Li Y, Park C, Jiang H, Li X, Vellón L
Int J Genomics, 2018:9016018, 24 Sep 2018
Cited by: 0 articles | PMID: 30402455 | PMCID: PMC6196791
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
Corominas-Faja B, Vellon L, Cuyàs E, Buxó M, Martin-Castillo B, Serra D, García J, Lupu R, Menendez JA
Histol Histopathol, 32(7):687-698, 07 Oct 2016
Cited by: 39 articles | PMID: 27714708 | PMCID: PMC5784426
Add to export list Free full text in Europe PMC
iPSCs: From Bench to Clinical Bed.
Li Y, Park C, Vellón L, Li X
Stem Cells Int, 2016:8367587, 22 Sep 2016
Cited by: 1 article | PMID: 27738437 | PMCID: PMC5055991
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells.
Menendez JA, Vellon L, Espinoza I, Lupu R
Oncoscience, 3(7-8):242-257, 22 Jul 2016
Cited by: 12 articles | PMID: 27713913 | PMCID: PMC5043073
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Heregulin, a new interactor of the telosome/shelterin complex in human telomeres.
Menendez JA, Benboudjema L, Vellon L, Rubio MA, Espinoza I, Campisi J, Lupu R
Oncotarget, 6(37):39408-39421, 01 Nov 2015
Cited by: 4 articles | PMID: 26327598 | PMCID: PMC4741835
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Blockade of a key region in the extracellular domain inhibits HER2 dimerization and signaling.
Menendez JA, Schroeder B, Peirce SK, Vellon L, Papadimitropoulou A, Espinoza I, Lupu R
J Natl Cancer Inst, 107(6):djv090, 16 Apr 2015
Cited by: 9 articles | PMID: 25888715
Add to export list
Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A, Cufí S, López-Bonet E, Corominas-Faja B, Cuyàs E, Vellon L, Iglesias JM, Leis O, Martín AG, Menendez JA
Cell Cycle, 12(22):3471-3477, 04 Oct 2013
Cited by: 31 articles | PMID: 24107627 | PMCID: PMC3906332
Add to export list Free full text in Europe PMC
Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
Menendez JA, Alarcón T, Corominas-Faja B, Cuyàs E, López-Bonet E, Martin AG, Vellon L
Cell Cycle, 13(3):358-370, 09 Jan 2014
Cited by: 8 articles | PMID: 24406535 | PMCID: PMC3956532
Add to export list Free full text in Europe PMC
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B, Cufí S, Oliveras-Ferraros C, Cuyàs E, López-Bonet E, Lupu R, Alarcón T, Vellon L, Iglesias JM, Leis O, Martín ÁG, Vazquez-Martin A, Menendez JA
Cell Cycle, 12(18):3109-3124, 21 Aug 2013
Cited by: 71 articles | PMID: 23974095 | PMCID: PMC3875684
Add to export list Free full text in Europe PMC
1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death.
Manterola L, Hernando-Rodríguez M, Ruiz A, Apraiz A, Arrizabalaga O, Vellón L, Alberdi E, Cavaliere F, Lacerda HM, Jimenez S, Parada LA, Matute C, Zugaza JL
Transl Psychiatry, 3:e219, 22 Jan 2013
Cited by: 32 articles | PMID: 23340502 | PMCID: PMC3566727
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
Vazquez-Martin A, Vellon L, Quirós PM, Cufí S, Ruiz de Galarreta E, Oliveras-Ferraros C, Martin AG, Martin-Castillo B, López-Otín C, Menendez JA
Cell Cycle, 11(5):974-989, 01 Mar 2012
Cited by: 70 articles | PMID: 22333578
Add to export list

1-25 of 56 results

1 2 3

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding